Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioNTech SE - ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BNTX
Nasdaq
8731
https://www.biontech.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioNTech SE - ADR
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value
- Mar 26th, 2024 5:00 am
UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties
- Mar 25th, 2024 10:47 am
BioNTech Full Year 2023 Earnings: Misses Expectations
- Mar 24th, 2024 12:59 pm
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
- Mar 23rd, 2024 12:33 pm
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
- Mar 21st, 2024 3:38 pm
Q4 2023 BioNTech SE Earnings Call
- Mar 21st, 2024 5:43 am
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
- Mar 20th, 2024 8:45 pm
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
- Mar 20th, 2024 7:38 pm
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
- Mar 20th, 2024 6:45 pm
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline
- Mar 20th, 2024 3:05 pm
BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
- Mar 20th, 2024 2:34 pm
UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches
- Mar 20th, 2024 10:22 am
BioNTech slides as earnings plunge amid cancer drug shift
- Mar 20th, 2024 10:17 am
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
- Mar 20th, 2024 10:15 am
After earnings plunge, BioNTech pins hopes on cancer drug launches
- Mar 20th, 2024 10:15 am
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
- Mar 20th, 2024 10:00 am
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
- Mar 17th, 2024 1:19 pm
Q4 2023 Autolus Therapeutics PLC Earnings Call
- Mar 15th, 2024 9:53 am
Autolus Therapeutics PLC Reports Full Year 2023 Financial Results
- Mar 14th, 2024 5:51 pm
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
- Mar 13th, 2024 3:07 pm
Scroll